论文信息 - Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17) - 字舞流文

Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17)

R. Greil | M. Gnant | R. Jakesz | C. Singer | G. Steger | M. Fridrik | F. Ploner | B. Mlineritsch | C. Menzel | C. Tausch | P. Wohlmuth | M. Stierer | G. Luschin-Ebengreuth | A. Urbania | E. Melbinger | Colorectal Cancer Study Group on behalf of the Austrian Breast | Elisabeth Melbinger